Dr. Hagen Kennecke, a medical oncologist and medical director of gastrointestinal oncology at Providence, talks about what inspires him in his career.
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
Patient describes lung cancer journey as “easy” thanks to Providence’s multidisciplinary cancer care team
Lung nodule clinic: Game-changing technology, superb physicians and caregivers help lead great-grandmother from diagnosis to recovery in two months.
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
March is Colorectal Cancer Awareness Month, and Providence is offering a list of resources to help you learn about the disease and screening options.
Providence researchers are studying a blood-based, multi-cancer early detection test able to detect more than 50 cancer types through a single blood draw.
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
As part of an international data-sharing consortium of leading cancer centers, Providence Cancer Institute and Swedish Cancer Institute work together to provide genomic data to Project GENIE.
The Commission on Cancer, a quality program of the American College of Surgeons, has awarded a three-year accreditation to the cancer program at Providence Alaska Medical Center.
Depending on your age, there are a number of recommended cancer screenings. Here’s a list of the different kinds of screenings.
In the days leading up to a colonoscopy, it’s a good idea to eat foods that are low in fiber. Here, we give you some ideas.
Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
Providence Saint John’s opens last phase of clinical trial of promising drug for aggressive brain cancer
One patient tells his inspiring story of recovery
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
Leonard Cancer Institute Earns Accreditation from the National Accreditation Program for Rectal Cancer of the American College of Surgeons
Providence Mission Hospital and the Judi and Bill Leonard Cancer Institute for Prevention, Treatment and Wellness recently earned a three-year accreditation from the NAPRC.
During Cervical Health Awareness Month, take charge of your cervical health with testing and vaccination aimed at preventing cervical cancer.
It’s National Blood Donor Month, and we’re giving you the basic facts about who can donate blood and what it’s like.
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
The urology team at Providence St. Joseph Hospital helps patients seeking prostate treatment, whether that be initial screenings, pelvic therapy referrals, or robotic surgery procedures.